By Cameron Chai
Research and Markets has included a new report titled ‘World Hematology and Flow Cytometry Market Outlook: Growth Opportunities and Business Expansion Strategies’ to its database.
The comprehensive report will be helpful to existing suppliers and emerging market entrants for identifying and assessing potential opportunities in the global flow cytometry and hematology markets over the next 10 years. It covers upcoming technological and marketing in seven nations.
The 700-page report provides data pertaining to instrument placements, test volume forecasts and market share estimates. It includes feature comparison of more than 60 analyzers and also features profiles of emerging market entrants and major competitors.
According to the report, the global hematology and flow cytometry markets will be affected by continual developments in monoclonal antibodies, lasers, molecular diagnostics and IT, and growing knowledge of immunologic forces controlling systemic diseases over the next 10 years.
Novel monoclonal antibody and molecular diagnostic tests will make the current procedures easy and offer basis for simple, specific and sensitive assays. The introduction of compact and user-friendly laser systems will further extend flow cytometry applications to custom clinical laboratories.
Further development in IT will decrease the cost of instrument production service and service warranty, and allow development of auto-calibration, self-troubleshooting and other sophisticated features. Current tedious analyses of lymphocyte subsets, DNA content and chromosomal abnormalities will turn out to be more automated and habitual.
DNA content analysis, RNA content analysis, chemotherapy monitoring, cell cycle analysis, chromosome analysis, protein content analysis and multiparameter analysis are some of the major flow cytometry applications discussed in the report. Companies mentioned in the report include Abbott, Beckman Coulter, Becton Dickinson, Bio-Rad, DakoCytomation, Horiba, Iris, J&J Diagnostics, Nihon Kohden, Roche, Siemens and Sysmex.